Pieris Pharmaceuticals
PIRS
#9919
Rank
A$28.07 M
Marketcap
$21.26
Share price
-15.58%
Change (1 day)
15.80%
Change (1 year)

Earnings for Pieris Pharmaceuticals (PIRS)

Earnings in 2024 (TTM): -A$33.78 Million

According to Pieris Pharmaceuticals's latest financial reports the company's current earnings are A$19.57 Million. In 2022 the company made an earning of -A$52.03 Million, an increase over its 2021 earnings that were of -A$71.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Pieris Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$33.78 Million
2022 -A$52.03 Million-27.24%
2021 -A$71.52 Million23.4%
2020 -A$57.96 Million45.53%
2019 -A$39.83 Million-5.89%
2018 -A$42.32 Million63.59%
2017 -A$25.87 Million-26.92%
2016 -A$35.4 Million63.39%
2015 -A$21.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.13 Billion 258.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$8.58 Million-75.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.07 B-3,219.21%๐Ÿ‡บ๐Ÿ‡ธ USA